Randomized Trial of Active vs Passive Splinting for Extensor Tendon Injuries in Zones IV to VI

April 22, 2025 updated by: Fundacin Biomedica Galicia Sur

A Randomized Controlled Trial Comparing Active and Passive Motion Splint Immobilization for the Treatment of Extensor Tendon Injuries in Zones IV to VI of the Hand

This study compares two methods of post-operative immobilization after surgical repair (tenorrhaphy) of extensor tendons in the fingers. Patients were randomly assigned to receive either a standard plaster splint or an alternative splinting method that allows controlled finger movement (ICAMS). The main goal was to determine which method leads to better recovery in terms of finger mobility, grip strength, pain, and patient comfort.

Study Overview

Detailed Description

Extensor tendon injuries of the hand are commonly treated with immobilization for 4-6 weeks using a plaster splint in the intrinsic plus position. However, prolonged immobilization may lead to tendon adhesions, joint stiffness, and delayed return to function. This randomized controlled clinical trial evaluated the efficacy of an immediate controlled active motion splinting protocol (ICAMS) compared to classic immobilization (CI) following extensor tendon tenorrhaphy in zones IV, V, and VI. Thirty patients were randomly assigned to either group. Functional outcomes were assessed at 4 and 6 weeks post-injury, including grip strength, joint range of motion, pain (VAS), Quick-DASH score, and patient satisfaction. The ICAMS group showed significantly better results in all main functional parameters. These findings support the use of early active motion protocols in selected cases of extensor tendon injury to enhance recovery and patient comfort.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pontevedra
      • Vigo, Pontevedra, Spain, 36312
        • CHUVI Hospital (Complejo Hospitalario Universitario de Vigo)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years or older
  • Patients from the CHUVI Health Area
  • Diagnosed with an acute, single, complete extensor tendon laceration in zones IV, V, or VI of the long fingers
  • Treated with primary tenorrhaphy
  • Provided signed informed consent
  • Agreed to attend follow-up visits and comply with the study protocol

Exclusion Criteria:

  • More than one extensor tendon laceration in the same hand
  • Injuries involving the thumb
  • Tendon injuries with loss of substance
  • Associated injuries at the same level (e.g., bone fracture, nerve lesion)
  • Patients with cognitive impairment or inability to follow the protocol
  • Presence of other injuries or medical conditions that could interfere with assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ICAMS Group
Participants received immediate controlled active motion splinting (ICAMS) after extensor tendon tenorrhaphy. The ICAMS protocol included a daytime yoke splint, which maintained the injured finger in 20° more extension than adjacent fingers, and a nocturnal intrinsic plus static splint. The protocol was maintained for 4 weeks post-surgery
The ICAMS protocol consisted of a daytime yoke splint maintaining the injured finger in 20° more extension than adjacent fingers, combined with a nocturnal static splint in the intrinsic plus position. The splinting was applied for 4 weeks following extensor tendon tenorrhaphy.
Other Names:
  • Immediate Controlled Active Motion Splinting
  • Dynamic Splint
  • Yoke Splint
Active Comparator: Classic Immobilization Group
Participants received standard immobilization with a plaster splint in the intrinsic plus position following extensor tendon tenorrhaphy. The immobilization was maintained continuously for 4 weeks.
Participants received a classic plaster splint in the intrinsic plus position worn continuously for 4 weeks following extensor tendon tenorrhaphy.
Other Names:
  • Intrinsic Plus Position Splint
  • Standard Immobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Grip Strength of the Injured Hand
Time Frame: 4 and 6 weeks after injury
Grip strength was measured using a JAMAR manual dynamometer to evaluate functional recovery after extensor tendon tenorrhaphy. Measurements were taken at 4 and 6 weeks post-injury.
4 and 6 weeks after injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in MCP Joint Flexion
Time Frame: 4 and 6 weeks after injury
Active flexion of the metacarpophalangeal (MCP) joints of the injured finger was measured to assess recovery of joint mobility.
4 and 6 weeks after injury
Pain Intensity (VAS Score)
Time Frame: 4 and 6 weeks after injury
Pain was evaluated using a 10-point Visual Analog Scale (VAS) at both follow-up visits.
4 and 6 weeks after injury
Quick-DASH Score
Time Frame: 4 and 6 weeks after injury
Upper limb disability and function were assessed using the Quick Disabilities of the Arm, Shoulder, and Hand (Quick-DASH) questionnaire.
4 and 6 weeks after injury
Patient Comfort With Immobilization
Time Frame: 4 and 6 weeks after injury
Patients rated their comfort with the splint using a yes/no response at 4 weeks post-treatment.
4 and 6 weeks after injury
Patient Satisfaction With Treatment Outcome
Time Frame: 4 and 6 weeks after injury
Patients reported overall satisfaction with the treatment using a yes/no response.
4 and 6 weeks after injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Miguel Cela-López, MD, Sergas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Actual)

August 25, 2021

Study Completion (Actual)

August 30, 2021

Study Registration Dates

First Submitted

April 22, 2025

First Submitted That Met QC Criteria

April 22, 2025

First Posted (Actual)

April 30, 2025

Study Record Updates

Last Update Posted (Actual)

April 30, 2025

Last Update Submitted That Met QC Criteria

April 22, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendon Injuries

Clinical Trials on ICAMS Splinting Protocol

Subscribe